Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction

Area of Science:

• Ophthalmology
• Ocular Surface Disease
• Medical Technology

Background:

• Meibomian gland dysfunction (MGD) is a common condition affecting the ocular surface.
• Altered lipid layer and meibomian gland structure characterize MGD.
• Effective treatment options for MGD are continuously sought.

Purpose of the Study:

• To evaluate the clinical outcomes of combined intense pulsed light (IPL) and low-level light therapy (LLL) in patients with MGD.
• To assess the safety and efficacy of this combined therapeutic approach.

Main Methods:

• A prospective study involving MGD patients with specific diagnostic criteria.
• Treatment involved a combination of IPL and LLL.
• Multimodal assessments were conducted pre-treatment, and at 2-3 weeks and 6 months post-treatment.

Main Results:

• Significant improvement in lipid layer thickness (LLT) was observed 6 months post-treatment.
• Ocular Surface Disease Index (OSDI) scores decreased significantly, indicating symptom reduction.
• Schirmer test (ST) improved, while tear osmolarity (OSM) worsened; other parameters showed no significant change.
• No adverse effects were reported during the study.

Conclusions:

• Combined IPL and LLL therapy is effective and safe for managing MGD.
• The treatment successfully enhances lipid layer thickness and alleviates patient symptoms.
• This approach represents a valuable addition to MGD treatment modalities.